BMP 7 gene therapy

Drug Profile

BMP 7 gene therapy

Alternative Names: Ad-BMP-7; periodontal dental gene therapy

Latest Information Update: 27 Apr 2007

Price : $50

At a glance

  • Originator University of Michigan
  • Class
  • Mechanism of Action Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Periodontal disorders

Most Recent Events

  • 25 Aug 2006 No development reported - Preclinical for Periodontal disorders in USA (unspecified route)
  • 22 Oct 2003 Preclinical data from a media release have been added to the Mouth disorders pharmacodynamics section
  • 28 Feb 2003 Preclinical trials in Periodontal disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top